Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Date:8/8/2011

MALVERN, Pa., Aug. 8, 2011 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that Dr. James P. Tursi has been promoted to Chief Medical Officer. Dr. Tursi will report to Armando Anido, Chief Executive Officer and President of Auxilium, and sit on the Auxilium Executive Committee in this role.

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO)

Dr. Tursi has been employed at Auxilium since March of 2009 and has been responsible for the oversight of clinical development, clinical operations, biometrics and medical writing.  He led a team of 30 individuals involved in clinical activities across several indications.  Dr. Tursi played critical roles in the preparation, submissions and approvals of the XIAFLEX® U.S. biologics license application and XIAPEX® European marketing authorization application for Dupuytren's contracture, as well as design of subsequent phase IV clinical trials.  He also has led the Peyronie's phase III program development and overseen enrollment of these pivotal clinical studies.  

Prior to Auxilium, Dr. Tursi entered the pharmaceutical industry in 2004 as a medical director for Procter and Gamble Pharmaceuticals. He worked on several products and therapeutic areas, which included female sexual dysfunction, overactive bladder, and osteoporosis. His responsibilities included Clinical Development and Medical Affairs. He moved to GlaxoSmithKline Biologicals in 2006 and directed all Medical Affairs responsibilities for cancer vaccines in North America.  

Dr. Tursi received his doctor of medicine degree from the Medical College of Pennsylvania. He subsequently completed his training in Gynecology and Obstetrics at the Johns Hopkins Hospital and entered clinical practice in Southern New Jersey caring for indigent patients. He pr
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Minn. , May 23, 2013  MGC Diagnostics ... a global medical technology company, today scheduled a conference ... quarter of fiscal year 2013, ended April 30, 2013. ... Thursday, May 30, 2013. The Company will report financial ... after the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... More than half of women diagnosed with ... and still have excellent outcomes. To educate women, Agendia, ... largest sources of online consumer information about breast cancer ... provide recently diagnosed women with information sources, to help ... "We anticipate these innovative social media campaigns will ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... a global leader in sourcing commercial drugs for clinical ... joined the company as Director, International Supply Services. He ... Matt brings to Myoderm 12 years experience working in ... companies. While at AstraZeneca, he was an R&D Sourcing ...
... 2012   CareFusion today announced its Alaris ... infusion system to receive a new data encryption certification ... of Veterans Affairs hospital networks. (Logo: ... Information Processing Standard (FIPS) 140-2, certifies that the ...
Cached Medicine Technology:CareFusion Receives Federal Data Encryption Certification for Alaris® Infusion System 2
(Date:5/24/2013)... May 2013, Paris, France: Routinely measuring fractional flow ... angiography for diagnosis of chest pain leads to ... four patients, according to results from a study ... routine pressure wire assessment influence management strategy at ... was designed to assess whether routine assessment of ...
(Date:5/24/2013)... Oregon Health & Science University highlights an ingenious method ... the highly evasive HIV virus that causes AIDS. The ... approach to develop its own HIV vaccine candidate, which ... This latest research finding will be published in the ... . , "A major challenge in developing an ...
(Date:5/24/2013)... 2013 CBT News.com recently announced the addition ... web-based retail automotive industry news organization with 12 years experience ... to join a group that’s so forward-thinking in their approach,” ... online video content is on the rise.” , Atlanta born ... and segued into advertising at Cycle News and Boating World. ...
(Date:5/24/2013)... American International College of Arts ... articulation agreement with Old Dominion University (ODU) ... Antigua. , The program will permit ODU ... a cell biology course, taught by AICASA’s faculty, for ... University of Antigua (AUA) College of Medicine , students ...
(Date:5/24/2013)... children who missed more than half of recommended well-child ... compared to children who attended most of their visits, ... American Journal of Managed Care . The study included ... , Children with chronic conditions like asthma and ... when they missed visits, according to the study. ...
Breaking Medicine News(10 mins):Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3
... Wash., Sept. 15 Edifecs, the leader in ... has,selected the Edifecs Healthcare Accelerator Suite to automate ... and batch modes,within the product and development areas ... Sunny Singh, Edifecs, CEO said: "In response ...
... Misys Resolve Dispute, DALLAS, Sept. 15 iMedica ... dispute with Misys,Healthcare Systems LLC ("Misys")., Under the ... iMedica,PRM 2008 practice management (PM) and electronic health record ... its customers. The,agreement also states that iMedica will provide ...
... grant from the National Cancer Institute to find out ... tailored education in the user,s preferred language increases the ... The funding will be used to refine custom-designed software, ... evaluate its clinical impact in primary care physician,s offices ...
... Li, associate professor of biological sciences at Virginia ... cellular innate immunity network and human chronic inflammatory ... diseases. The finding presents a viable cellular and ... serious human inflammatory diseases, according to Li. ...
... advice , , MONDAY, Sept. 15 (HealthDay News) -- A ... about how they can preserve their ability to have ... , "It,s overwhelming for cancer patients to have ... same time that they are struggling to come to ...
... 15 Optical Cable,Corporation (Nasdaq: OCCF ), announced ... 2008 results today, September 15, 2008. The third,quarter results ... 2008. In conjunction with its release, the Company will ... 10:00 a.m. Eastern Time., Individuals wishing to participate ...
Cached Medicine News:Health News:Unisys Selects Edifecs Healthcare Accelerator Suite(TM) for MMIS System 2Health News:iMedica Announces Agreement with Misys 2Health News:UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics 2Health News:Key protein molecule linked to diverse human chronic inflammatory diseases 2Health News:Web Site Helps Cancer Patients With Fertility Preservation 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 3
... The RELISA ENA Multiparameter ... patient samples for six of ... kit features a unique quality ... (RELISA Procedure Check) well in ...
... Screening Kit is designed to screen patient samples ... microtiter well is coated with Sm, RNP, SS-A, ... laboratory to cost effectively screen out the ENA ... specificity on any of the company's other RELISA ...
... a host defense against foreign antigens and ... cleared, CIC may be deposited in tissue ... in Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis ... autoimmune disorders as well as in infectious ...
... Urine Controls are supplied as ... requiring no reconstitution or dilution. ... urine, fortified to target levels ... Preservatives including sodium azide have ...
Medicine Products: